Print Version
Latest News Releases
2010
February 8, 2010 - Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants them exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses.
February 1, 2010 - New Form of Stem Cell Communication Rescues Diseased Neurons
Investigators at Sanford-Burnham Medical Research Institute, the Karolinska Institutet, Beth Israel Deaconess Medical Center, Harvard Medical School and Université Libre de Bruxelles have demonstrated in mouse models that transplanted stems cells, when in direct contact with diseased neurons, send signals through specialized channels that rescue the neurons from death.
January 27, 2010 - Secrets of Immunologic Memory
Investigators at Sanford-Burnham Medical Research Institute have discovered a new way the cell surface protein, CD44, helps specific T helper (Th1) cells develop immunologic memory.
January 26, 2010 - T. Denny Sanford Donates $50 Million to Burnham Institute for Medical Research
Burnham Institute for Medical Research announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute’s leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute.
January 11, 2010 - Team Burnham's Passion for Science Provides Fuel for the Walt Disney World Marathon
Burnham Institute for Medical Research's Team Burnham, represented by over 60 runners, rallied for the third consecutive year to compete in the Walt Disney World full and half marathons on January 9 and 10, 2010. Team members are driven by a passion to "run for discovery" and are raising awareness and funds in support of basic medical research.
2009
December 21, 2009 - How Flu Succeeds
Investigators have identified 295 human cell factors that influenza A strains must harness to infect a cell, including the currently circulating swine-origin H1N1. The team also identified small molecule compounds that act on several of these factors and inhibit viral replication, pointing to new ways to treat flu.
December 16, 2009 - Burnham Institute for Medical Research Wins Gold for Green Design
Burnham Institute for Medical Research at Lake Nona has received a gold level Leadership in Energy and Environmental Design (LEED ®) certification by the Green Building Certification Institute. The award recognizes the Institute’s innovation in design, eco-friendly building construction and commitment to sustainability.
December 7, 2009 - Delivering Medicine Directly into a Tumor
Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara have identified a peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal tissues. The peptide was also shown to deliver diagnostic particles and medicines into the tumor.
December 7, 2009 - Burnham Institute for Medical Research Executive Vice President, Dr. Gary F. Raisl, Assumes Chief Financial Officer Duties
Burnham Institute for Medical Research has appointed Executive Vice President Gary F. Raisl, Ed.D., to the position of Chief Financial Officer. In this role, Dr. Raisl will provide strategic direction and oversee the day-to-day financial operations of Burnham’s California and Florida campuses.
November 16, 2009 - Dr. Daniel Kelly, Scientific Director of Burnham at Lake Nona Receives American Heart Association’s 2009 Basic Research Prize
The prize recognizes Dr. Kelly as an international authority on the molecular biology and physiology of cardiac metabolism and as a physician-scientist who projects a vision of how basic research can translate into clinically beneficial treatments.
November 15, 2009 - Researchers Find Potential Treatment for Huntington’s Disease
Investigators at Burnham Institute for Medical Research, the University of British Columbia’s Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington’s disease.
November 11, 2009 - Mouse Gene Suppresses Alzheimer’s Plaques and Tangles
Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major players in Alzheimer’s disease: amyloid beta and tau. The amyloid and tau lowering functions of this gene were demonstrated in both human and mouse cells. Amyloid beta is responsible for the plaques found in the brains of Alzheimer’s patients. Tau causes the tangles found within patients’ brain cells.
October 20, 2009 - Burnham Institute for Medical Research Appoints First Chief Business Officer
Burnham Institute for Medical Research announced today that Dr. Paul Laikind will join Burnham as Senior Vice President, Business Development and Chief Business Officer in November. Dr. Laikind is a seasoned entrepreneur with extensive experience in business development. He is the cofounder of three biotech companies – Gensia Pharmaceuticals, Viagene and Metabasis Therapeutics.
October 16, 2009 - Burnham Honors Postdoctoral Fellows
Burnham Institute for Medical Research has announced that five of its postdoctoral research fellows have been honored with Fishman Fund Awards to recognize their commitment to basic biomedical research. The awardees received $5,000 grants to be used to further their education and career development.
October 9, 2009 - Translasome Contains Alpha And Omega of Protein Metabolism
Researchers at Burnham Institute for Medical Research, Baylor College of Medicine and other institutions have found that eukaryotic initiation factor 3 (eIF3), which is critical to translate genetic messages into proteins, is part of a large protein complex called the translasome, which contains the majority of the proteins needed to regulate both protein synthesis and protein degradation.
October 8, 2009 - Burnham Institute for Medical Research Expands Scientific Boundaries with Dedication at Lake Nona
Today, Burnham Institute for Medical Research officially dedicated its new 175,000-square-foot scientific facility and marked the opening of Orlando’s Medical City as a life science center.
October 8, 2009 - University of Florida Formalizes Commitment to Locate Research Facility in Orlando
The University of Florida has reached a milestone in its efforts to build a research facility in Orlando at the emerging Lake Nona Medical City. A ceremony marking the official signing of the agreements was held immediately preceding the formal dedication of Burnham Institute for Medical Research’s Lake Nona campus.
September 21, 2009 - Burnham Appoints Michael R. Jackson, Ph.D., Vice President for Drug Discovery & Development
Burnham Institute for Medical Research has appointed Michael R. Jackson, Ph.D., to the newly created position of Vice President for Drug Discovery and Development. In this role, Dr. Jackson will oversee the chemical biology and drug discovery efforts of the Conrad Prebys Center for Chemical Genomics (CPCCG) at Burnham’s La Jolla, California and Orlando, Florida campuses.
September 21, 2009 - How Proteins Talk to Each Other
Investigators at Burnham Institute for Medical Research have identified novel cleavage sites for the enzyme caspase-3 (an enzyme that proteolytically cleaves target proteins). Using an advanced proteomic technique called N-terminomics, Guy Salvesen, Ph.D., professor and director of the Apoptosis and Cell Death Research program of Burnham’s NCI-designated Cancer Center, and colleagues determined the cleavage sites on target proteins and found, contrary to previous understanding, that caspase-3 targets α-helices as well as unstructured loops.
September 17, 2009 - Burnham Institute for Medical Research and Duke University Sarah W. Stedman Nutrition and Metabolism Center Announce Metabolic Research Collaboration
A new collaborative research program that will use the power of metabolomic profiling to help advance the concept of personalized medicine was announced September 17, 2009 by the Burnham Institute for Medical Research and the Sarah W. Stedman Nutrition and Metabolism Center at Duke University Medical Center.
September 17, 2009 - Building a Complete Metabolic Model
Investigators at Burnham Institute for Medical Research , University of California, San Diego, The Scripps Research Institute), Genomics Institute of the Novartis Research Foundation and other institutions have constructed a complete model, including three dimensional protein structures, of the central metabolic network of the bacterium Thermotoga maritima (T. maritima).
September 15, 2009 - Reactive Oxygen’s Role in Metastasis
Researchers at the Burnham Institute for Medical Research (Burnham) have discovered that reactive oxygen species, such as superoxide and hydrogen peroxide, play a key role in forming invadopodia, cellular protrusions implicated in cancer cell migration and tumor metastasis.
September 14, 2009 - New Insights Into Cardiac Aging
Investigators at Burnham Institute for Medical Research have found that the conserved protein d4eBP modulates cardiac aging in Drosophila (fruit flies). The team also found that d4eBP, which binds to the protein dEif4e, protects heart function against aging.
September 11, 2009 - When Proteins Change Partners
Dieter Wolf, M.D., and colleagues at Burnham Institute for Medical Research have illuminated how competition between proteins enhances combinatorial diversity during ubiquitination (the process that marks proteins for destruction).
August 27, 2009 - The Path to New Antibiotics
Researchers at Burnham Institute for Medical Research, University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens. In addition, investigators discovered chemical compounds that can inhibit this enzyme and suppress the growth of pathogenic bacteria. These findings are essential to develop new broad-spectrum antibacterial agents to overcome multidrug resistance.
August 18, 2009 - Scientific Excellence Fuels Burnham’s Growth
In its 33rd year, Burnham Institute for Medical Research has surpassed significant milestones in scientific achievement, research staffing and infrastructure development. As of July 1, 2009, the Institute exceeded 1,000 employees, including 74 full-time faculty and 800 scientific staff.
August 17, 2009 - Florida Hospital and Burnham Institute Announce New Executive Director and Facility for Clinical Research Institute
Florida Hospital and Burnham Institute for Medical Research at Lake Nona have taken another giant step in advancing Orlando as a hub for medical research. Today, officials from Florida Hospital and Burnham Institute came together to announce the appointment of Dr. Steven R. Smith, an internationally-renowned diabetes and obesity researcher, as the new executive director of the Florida Hospital - Burnham Clinical Research Institute that focuses on the study of diabetes, obesity and cardiovascular disease.
August 12, 2009 - New Insights into Limb Formation
Investigators at Burnham Institute for Medical Research and the University of Connecticut Health Center have gained new understanding of the role hyaluronic acid (HA) plays in skeletal growth, chondrocyte maturation and joint formation in developing limbs.
August 10, 2009 - UC Santa Barbara and Burnham Institute for Medical Research Announce Director of New Joint Research Center for Nanomedicine
Burnham Institute for Medical Research (Burnham) and the University of California, Santa Barbara (UCSB) have named leading biomedical researcher Jamey D. Marth director of a new joint Center for Nanomedicine that will be established at UCSB.
August 10, 2009 - Burnham Institute for Medical Research Chosen as Comprehensive Center in New National Cancer Institute Chemical Biology Consortium
Burnham Institute for Medical Research has been selected as a comprehensive center in a new National Cancer Institute (NCI) Chemical Biology Consortium, an integrated network of chemical biologists, molecular oncologists and chemical screening centers. The consortium will establish a new paradigm in the use of public-private partnerships to translate knowledge from leading academic institutions into new drug treatments for patients with cancer.
August 6, 2009 - What Makes Stem Cells Tick?
Investigators at the Burnham Institute for Medical Research and The Scripps Research Institute have made the first comparative, large-scale phosphoproteomic analysis of human embryonic stem cells (hESCs) and their differentiated derivatives. The data may help stem cell researchers understand the mechanisms that determine whether stem cells divide or differentiate, what types of cells they become and how to control those complex mechanisms to facilitate development of new therapies.
August 5, 2009 - Unraveling How Cells Respond to Low Oxygen
Gary Chiang, Ph.D., and colleagues at Burnham Institute for Medical Research have elucidated how the stability of the REDD1 protein is regulated. The REDD1 protein is a critical inhibitor of the mTOR signaling pathway, which controls cell growth and proliferation.
August 3, 2009 - Burnham Institute for Medical Research Faculty Appointed to BioFlorida’s Board of Directors
Burnham Institute for Medical Research at Lake Nona today announced the appointment of Dr. Stephen Gardell to the Board of Directors of BioFlorida. Dr. Gardell’s appointment was approved by BioFlorida’s Board at their July meeting.
July 24, 2009 - Protein That Promotes Cancer Cell Growth Identified
Scientists at Burnham Institute for Medical Research have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer cells to proliferate, migrate and invade surrounding tissues.
July 13, 2009 - Burnham Institute for Medical Research Strengthens Research Programs with New Faculty Appointments
Burnham Institute for Medical Research at Lake Nona today announced two new faculty appointments to the Diabetes and Obesity Research Center. The newest research team members include: Julio Ayala, Ph.D., Assistant Professor, and Ranjan Perera, Ph.D., Associate Professor.
July 6, 2009 - Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
Magellan BioScience Group, Inc. (Magellan), a pioneer in innovative drug development from marine sources, and investigators at the Burnham Institute for Medical Research at Lake Nona (Burnham) announced today that they will begin a multidisciplinary drug discovery collaboration to identify novel marine microbial compounds that have potential as tools for biological research and ultimately the discovery of new medicines.
July 6, 2009 - Carbohydrate Acts as Tumor Suppressor
Scientists at Burnham Institute for Medical Research have discovered that specialized complex sugar molecules (glycans) that anchor cells into place act as tumor suppressors in breast and prostate cancers. These glycans play a critical role in cell adhesion in normal cells, and their decrease or loss leads to increased cell migration by invasive cancer cells and metastasis.
June 25, 2009 - MicroRNAs Help Control HIV Life Cycle
Scientists at Burnham Institute for Medical Research have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells. In particular, miR29 plays a key role in controlling the HIV life cycle. The study suggests that HIV may have co-opted this cellular defense mechanism to help the virus hide from the immune system and antiviral drugs.
June 15, 2009 - Burnham Institute for Medical Research Accelerates Bi-Coastal Expansion at Florida Campus
Burnham Institute for Medical Research is continuing its bi-coastal expansion with the appointment of the director of the Metabolic Signaling and Disease Program in the Diabetes and Obesity Research Center at its campus in Lake Nona, located in Orlando, Florida.
June 9, 2009 - Embryology Study Offers Clues to Birth Defects
Gregg Duester, Ph.D., professor of developmental biology at Burnham Institute for Medical Research, along with Xianling Zhao, Ph.D., and colleagues, have clarified the role that retinoic acid plays in limb development.
May 15, 2009 - Burnham Campus “Green” Design Fact Sheet
The Burnham Institute for Medical Research’s new research center in Orlando is the largest private research facility in the state that is tracking toward a gold level LEED certification.
May 15, 2009 - Burnham Scientists Receive Key to New Lake Nona Campus
Burnham Institute for Medical Research commemorated the completion of its new facility on Friday, as scientists received the key to the new research building from Orlando Mayor Buddy Dyer and Orange County Mayor Richard T. Crotty.
April 17, 2009 - Burnham Researchers Present at 100th AACR Meeting
Burnham Institute for Medical Research (Burnham) is pleased to announce that five of its postdoctoral fellows will present seven papers on their data at the American Association for Cancer Research (AACR) 100th Annual Meeting 2009. In addition, John C. Reed, M.D., Ph.D., Burnham President and CEO, Professor and Donald Bren Presidential Chair, will chair a panel on Apoptosis-based Strategies for Cancer Therapy, where he will also present his own research.
April 22, 2009 - Moving Microbes & Microscopes: Burnham Institute for Medical Research begins move to new campus
Scientists at Burnham Institute for Medical Research began packing and moving their laboratories and high tech equipment today for transport to a new state-of-the-art campus at the “medical city” in Lake Nona.
April 13, 2009 - Creating Ideal Neural Cells for Clinical Use
Investigators at Burnham Institute for Medical Research have developed a protocol to rapidly differentiate human embryonic stem cells (hESCs) into neural progenitor cells that may be ideal for transplantation. The research, conducted by Alexey Terskikh, Ph.D., and colleagues, outlines a method to create these committed neural precursor cells (C-NPCs) that is replicable, does not produce mutations in the cells and could be useful for clinical applications.
April 9, 2009 - Device Protects Transplanted Pancreatic Cells from the Immune System
Scientists at Burnham Institute for Medical Research and the University of California San Diego School of Medicine have demonstrated in mice that transplanted pancreatic precursor cells are protected from the immune system when encapsulated in polytetrafluorethylene (PTFE). The study, which suggests a new approach to treating Type 1 diabetes, was published online on April 8 in the journal Transplantation.
April 8, 2009 - Scientists Develop Method for Comprehensive Proteome Analysis
Investigators at Burnham Institute for Medical Research (Burnham) have deciphered a large percentage of the total protein complement (proteome) in Schizosaccharomyces pombe (S. pombe) fission yeast.
April 2, 2009 - Burnham Institute for Medical Research Demonstrates Commitment to Translational Research with New Faculty Appointment
Burnham Institute for Medical Research at Lake Nona today announced that Stephen J. Gardell, Ph.D. has joined the Institute as Director of Translational Research Resources and Adjunct Associate Professor.
April 2, 2009 - Alzheimer’s Disease Linked to Mitochondrial Damage
Investigators at Burnham Institute for Medical Research have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide—which causes a chemical reaction called S-nitrosylation—mediates neurodegeneration associated with Alzheimer’s disease. Prior to this study, the mechanism by which beta-amyloid protein caused synaptic damage to neurons in Alzheimer’s disease was unknown.
March 18, 2009 - Protein is Key to Embryonic Stem Cell Differentiation
Investigators at Burnham Institute for Medical Research have learned that a protein called Shp2 plays a critical role in the pathways that control decisions for differentiation or self-renewal in both human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs).
February 22, 2009 - Scientists Identify Human Monoclonal Antibodies Effective Against Bird and Seasonal Flu Viruses
Researchers at the Dana-Farber Cancer Institute, Burnham Institute for Medical Research and the Centers for Disease Control and Prevention have reported the identification of human monoclonal antibodies (mAb) that neutralize an unprecedented range of influenza A viruses, including avian influenza A (H5N1) virus, previous pandemic influenza viruses, and some seasonal influenza viruses. These antibodies have the potential for use in combination with other treatments to prevent or treat certain types of avian and seasonal flu.
February 12, 2009 - Stem Cell Research Uncovers Mechanism for Type 2 Diabetes
Taking clues from their stem cell research, investigators at the University of California San Diego and Burnham Institute for Medical Research have discovered that a signaling pathway involved in normal pancreatic development is also associated with type 2 diabetes.
January 29, 2009 - Philanthropist Conrad Prebys Donates $10 Million for Drug Discovery
San Diego philanthropist Conrad Prebys will donate $10 million to Burnham Institute for Medical Research to support the activities of Burnham’s drug discovery center, which is part of the world’s largest public drug discovery effort.
January 13, 2009 - Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Burnham Institute for Medical Research has signed an assay development and license agreement with Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD). The agreement is Burnham’s first broad-based partnership with a large pharmaceutical company.
January 9, 2009 - Digital Communication Technology Helps Clear Path to Personalized Therapies
Researchers at the Burnham Institute for Medical Research have shown that search algorithms used in digital communications can help scientists identify effective multi-drug combinations.
January 5, 2009 - Burnham Researchers Discover “On Switch” for Cell Death Signaling Mechanism
Scientists at Burnham Institute for Medical Research have determined the structure of the interactions between proteins that form the heart of the death inducing signaling complex (DISC), which is responsible for triggering apoptosis (programmed cell death).
January 5, 2009 - Burnham Researchers Illuminate Complex Mechanisms That Regulate DNA Damage Control and Replication in the Cell Cycle
Scientists at Burnham Institute for Medical Research have demonstrated important new roles for the protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring damage control during DNA replication and reinitiating replication following DNA repair. Since Ddk is often deregulated in human cancers, this new understanding of its role in DNA damage control could help shape new cancer therapies.
2008
December 19, 2008 - Peter Preuss Joins Burnham Institute for Medical Research Board
Burnham Institute for Medical Research has announced the election of Peter Preuss to its board of trustees. Preuss, president and founder of The Preuss Foundation, brings expertise in business, philanthropy and science to Burnham.
December 10, 2008 - Team Burnham Offers 10 Tips to Stay Healthy During the Holidays
Fresh from Saturday’s OUC Half Marathon and 5K, Team Burnham offers these survival tips for how to enjoy the festivities, while avoiding the infamous “holiday 10.”
December 2, 2008 - Burnham and HeadNorth Foundation Join Forces to Advance Spinal Cord Research
HeadNorth Foundation has pledged $975,000 to Burnham Institute for Medical Research to support cutting-edge stem cell research.
December 1, 2008 - Fruit Fly Research May Lead to Better Understanding of Human Heart Disease
Researchers at the Burnham Institute for Medical Research have shown in both fruit flies and humans that genes involved in embryonic heart development are also integral to adult heart function.
November 25, 2008 - Burnham Institute for Medical Research Announces New Faculty Appointments
Burnham Institute for Medical Research at Lake Nona today announced four new faculty appointments to the Diabetes and Obesity Research Center.
November 17, 2008 - Dr. Daniel Kelly Receives Distinguished Achievement Award from American Heart Association
Daniel Kelly, M.D., Scientific Director at Burnham Institute for Medical Research at Lake Nona received the 2008 Distinguished Achievement Award from the Council on Basic Cardiovascular Sciences at the American Heart Association Scientific Session in New Orleans last week.
November 12, 2008 - Burnham Institute for Medical Research Elects New Trustees
Burnham Institute for Medical Research (Burnham) announced the election of five new members to its board of trustees. These new trustees bring a wide variety of business, legal and philanthropic experience to Burnham.
October 13, 2008 - Fishman Awards Honor Gifted, Young Burnham Researchers
The Burnham Institute for Medical Research today announced that five of the Institute’s postdoctoral research associates will be honored with Fishman Fund Awards to recognize their commitment to basic biomedical research. The awardees will receive $5,000 grants to be used to further their education and career development.
October 10, 2008 - Burnham Institute for Medical Research Appoints Floridians to Board of Trustees
Burnham Institute trustees approved the appointment of two additional Floridians to the Board of Trustees at their September board meeting.
October 7, 2008 - Burnham Researchers Turn Cancer Friend into Cancer Foe
Burnham Institute announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer. The research, which was published as the featured article in the October 7 edition of Cancer Cell, may lead to new cancer treatments.
October 2, 2008 - What HIV Needs: Identification of human factors may yield novel therapeutic targets for HIV
The Salk Institute for Biological Studies and Burnham Institute for Medical Research today announced the identification of 295 host cell factors that are involved in human immunodeficiency virus (HIV) infection. The study, published in the Oct. 3 issue of Cell, could lead to the development of a new class of HIV therapeutics aimed at disrupting the human-HIV interactions that lead to viral infection.
September 16, 2008 - T. Denny Sanford Donates $30 Million to San Diego Consortium for Regenerative Medicine: Consortium of Four Research Institutions to be Renamed Sanford Consortium for Regenerative Medicine
The San Diego Consortium for Regenerative Medicine today announced that it has received a generous $30 million donation from T. Denny Sanford of South Dakota. In recognition of the donation, the Consortium is now known as the Sanford Consortium for Regenerative Medicine.
September 16, 2008 - Burnham Researcher Awarded $8 Million Grant: Will Study Environmental Causes of Parkinson’s Disease
Burnham Institute today announced that Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E. Webb Neuroscience, Aging, and Stem Cell Research Center at Burnham has been awarded $8 million, over five years, to establish a Center for Neurodegeneration Science (CNS). The center will study potential environmental causes of Parkinson’s disease. Funding for the center comes from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health.
September 8, 2008 - Deborah Robison Joins Burnham Institute for Medical Research as Communications Director for Burnham at Lake Nona
Burnham Institute has appointed Deborah Robison as Communications Director for Burnham at Lake Nona in Orlando, Florida. Robison will serve as the primary media liaison in Florida. Her responsibilities include communicating the research accomplishments of Burnham researchers to the general public and raising community awareness of Burnham and its contributions to the life science industry in Central Florida.
September 2, 2008 - Burnham Awarded $97.9 Million NIH Grant to Expand Small-Molecule Screening and Discovery Center
Burnham Institute for Medical Research announced today that it has been awarded a prestigious six-year, $97.9 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health (NIH). Burnham will equip and manage one of four comprehensive small-molecule screening and discovery centers in the nation. Burnham was selected from among some of the nation’s largest and most prestigious universities and medical research institutions.
August 21, 2008 - Karin Eastham Steps Down as Executive Vice President and Chief Operating Officer of Burnham Institute for Medical Research
Burnham Institute for Medical Research has announced that Karin Eastham, Executive Vice President and Chief Operating Officer and a member of the Board of Trustees has resigned effective September 30.
June 30, 2008 - Researchers Link Early Stem Cell Mutation to Autism
Burnham scientists have shown that neural stem cell development may be linked to Autism. The study demonstrated that mice lacking the myocyte enhancer factor 2C (MEF2C) protein in neural stem cells had smaller brains, fewer nerve cells and showed behaviors similar to those seen in humans with a form of autism known as Rett Syndrome.
